Ella Cheong

Key details

  • Job title:Senior Partner
  • Jurisdiction:Hong Kong

Ella Cheong is the senior partner of ELLALAN, where she focuses on all issues related to IP rights. Aside from founding the firm, Cheong has established agency firm Ella Cheong (Hong Kong and Beijing), which was recently sold with proceeds given to charity, and the Singapore firm of Ella Cheong. She works with small and medium-sized enterprises, social enterprises and charitable organisations. Cheong formerly served as chair of the Law Society of Hong Kong’s IP committee and is now its member of honour. She is an INTA President’s Award winner.

More profiles

Women In IP
Partner/Head of Asia IP & TMT Practice  
Women In IP
Partner   Charmayne is widely recognised as one of Malaysia's top IP and TMT lawyers, and was named as one of AsiaLaw‚Äôs Leading Lawyers since 2009 for IP. She has been listed as a leading individual in Legal 500 Asia Pacific for IT and Telecommunications since 2008 and listed as a "Leading Individual" for TMT in Legal 500 Asia-Pacific since 2018. She also has been ranked as a Leading Individual for Intellectual Property in Legal 500 Asia Pacific since 2018. Charmayne has been ranked for IP in Chambers Asia Pacific since 2009, which recently described her as 'Charmayne Ong has a strong market reputation for advisory work in Malaysia, particularly managing registrations of patents, trade marks and copyrights. She offers in-depth sectoral expertise in TMT and also handles work in other sectors.' Charmayne also was listed in the Managing IP's Top 250 Women in IP 2021. In addition, Charmayne was listed as "WIPR's Influential Women in IP 2020" by World IP Review and as one of 'Malaysia Top 100 Lawyers - The A List' by Asia Business Law Journal 2020. In 2022, Charmayne was ranked Band 2 for TMT by Chambers Asia-Pacific 2022 and recognised as a recommended practitioner in the Who's Who Legal (WWL): Telecoms & Media 2022.
Women In IP
Partner   During her 25-year career, Elaine Blais has led teams on cases across the pharmaceuticals industry where she has represented brands and generics, including Teva Pharmaceuticals, Dr. Reddy‚Äôs, MSN, Fresenius Kabi, Hikma, the Association for Accessible Medicines, and Boehringer Ingelheim. She specialises in the fields of stem cell technology, secure financial transactions, light-emitting diodes, and consumer products. She represents clients in arbitration proceedings, often addressing disputes arising out of licensing agreements involving a variety of technologies, including CRISPR-Cas9 gene-editing and biologics manufacturing. Blais is the founder of Goodwin‚Äôs award-winning biosimilars blog, www.bigmoleculewatch.com. She serves on the Kids in need of defense Boston Advisory Committee, the Boston Bar Association Council, and the American Intellectual Property Law Association diversity, equity and inclusion committee.